FutureCure Health Strengthens Access to Specialised Diagnosis for Balance Disorders
India’s growing burden of vertigo and balance disorders is prompting specialised healthcare expansion. FutureCure Health Private Limited, through its wholly owned subsidiary NeuroEquilibrium, is expanding its network of dedicated vertigo clinics in Gurugram to improve diagnosis and treatment outcomes for patients suffering from chronic dizziness and balance-related conditions.
Nearly six crore people in India suffer from vertigo and balance disorders, yet many cases remain misdiagnosed or treated only with symptom-suppressing medication instead of addressing the underlying cause. NeuroEquilibrium focuses on identifying the root cause of vertigo, whether it originates from the inner ear, brain, or the body’s balance system, enabling targeted treatment rather than temporary relief.
Specialised Clinics and Evidence-Based Treatment
Recognised as the world’s largest chain of vertigo clinics, NeuroEquilibrium works closely with hospitals, ENT specialists, and neurology centres to deliver evidence-based diagnosis and care. The company has diagnosed and treated more than 150,000 patients so far, significantly improving long-term outcomes for individuals dealing with persistent dizziness and balance disorders.
The company currently operates nine specialised clinics across Gurugram, located in Sector 28 (DLF Phase 1), Sector 56, Sushant Lok 2, South City 1, Sector 51, Sector 38, New Railway Road, Sector 90, and Palam Vihar. These centres aim to improve access to specialised treatment for patients across the city.
Dr. Anita Bhandari, Founder of FutureCure Health, highlighted the scale of the problem, noting that vertigo and dizziness are often misdiagnosed, leaving many patients untreated for years. She emphasised that the company’s experience treating over 150,000 patients demonstrates how accurate diagnosis can significantly improve outcomes.
Funding to Scale Technology-Driven Healthcare
FutureCure Health recently raised ₹104 crore in a completed funding round led by Carnelian Asset Management LLP along with other investors. The company had previously secured $4 million in 2022 from Kotak Alternate Asset Management, RVCF Ventures, and Unicorn India Ventures.
Rajneesh Bhandari, Founder of FutureCure Health, said the funding reinforces the company’s mission to build globally relevant healthcare technologies from India. He added that the company plans to scale NeuroEquilibrium across hospitals in India and international markets while expanding into chronic lifestyle diseases such as migraine and diabetes through technology-led diagnostics.
Keep building. Keep learning. Keep growing with StartupByDoc.